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Ginsenosides, the major active ingredients of ginseng,
show a variety of biomedical e⁄cacies such as antiaging
and antioxidation. Here, we investigate the protective
activity of the ginsenoside F1, an enzymatically modi-
¢ed derivative of ginsenoside Rg1, against ultraviolet-
B-induced damage in human HaCaT keratinocytes.
Ginsenoside F1 signi¢cantly reduced ultraviolet-B-in-
duced cell death and protected HaCaTcells from apop-
tosis caused by ultraviolet B irradiation. Furthermore,
ginsenoside F1 prevented ultraviolet-B-induced clea-
vage of poly(ADP-ribose) polymerase in HaCaT
cells. In search of the molecular mechanism responsible
for the antiapoptotic e¡ect of ginsenoside F1, we ¢nd
that protection from ultraviolet-B-induced apoptosis is
tightly correlated with ginsenoside-F1-mediated inhibi-
tion of ultraviolet-B-induced downregulation of Bcl-2
and Brn-3a expression. Key words: apoptosis/Bcl-2/ginse-
noside F1/HaCaT/ultraviolet B. J Invest Dermatol 121:607 ^
613, 2003
U
ltraviolet radiation (UV), in particular ultraviolet
B (UVB) with a wavelength range between 290
and 320 nm, is one of the most important envir-
onmental factors because of its hazardous health
e¡ects, which include generation of skin cancer
(De Gruijl et al, 1993), suppression of the immune system (Beissert
and Schwarz, 1999), and premature skin aging (Fisher et al, 1997).
One of the hallmark events of UV-exposed skin is the formation
of apoptotic keratinocytes, which die as sunburn cells within the
epidermis. Biochemical analyses reveal that UVB-irradiated kera-
tinocytes show DNA fragmentation accompanied by sequential
caspase activation (Takahashi et al, 1997).
The Bcl-2 protein is constitutively expressed in the human
epidermis and regulation of its expression level may have an im-
portant role in the generation of sunburn cells (Hockenbery et al,
1991; Rodriguez-Villanueva et al, 1995; Sermadiras et al, 1997). Bcl-
2 is an antiapoptotic protein that blocks apoptosis probably by
inhibiting the channel-forming activity of proapoptotic family
members like Bax (Adams and Cory, 1998). UVB irradiation has
been known to decrease Bcl-2 expression without alteration of
Bax expression in human keratinocytes (Gillardon et al, 1994).
Furthermore, Bcl-2-transfected HaCaTcells or Bcl-2-overexpres-
sing transgenic mice were shown to be resistant to UVB-induced
apoptosis (Haake and Polakowka, 1995; Takahashi et al, 2001).
Although these ¢ndings suggest that Bcl-2 is a key regulator in
the apoptotic pathway of UVB-irradiated skin, little is known
about the mechanisms governing the downregulation of Bcl-2
expression caused by UVB irradiation.
Ginsenosides represent the major active ingredients of ginseng,
which show a variety of biomedical e⁄cacies, such as immune
modulation, antiaging, anti-in£ammation, and antioxidation in
the central nervous, cardiovascular, endocrine, and immune sys-
tems (Wang et al, 2000; Yu and Li, 2000; Chen et al, 2001). More
than 20 ginsenosides have been isolated and identi¢ed to date
(Gillis, 1997). Ginsenoside Rg1 prevents rat cortical neurons from
apoptosis (Li et al, 1997), whereas ginsenoside Rh2 inhibits
growth in various cancer cells (Ota et al, 1987). The action me-
chanism and potential role of ginsenosides in keratinocytes, how-
ever, are poorly understood.
In this study we have investigated the role of a ginsenoside in
UVB-induced apoptosis of keratinocytes. For the study, the gin-
senoside F1 (20-O-b-D-glucopyranosyl-20 (S)-protopanaxatriol),
an enzymatically modi¢ed molecule of ginsenoside Rg1, is used
(Fig 1).We have shown that UVB irradiation downregulates Bcl-
2 expression via a downregulation of Brn-3a transcription factor
in HaCaT cells, and ginsenoside F1 protects these cells against
UVB-induced apoptosis by maintaining constant levels of Brn-
3a and the corresponding inhibition of Bcl-2 downregulation.
MATERIALS ANDMETHODS
Ginsenoside F1 preparation Ten grams of total ginseng extracts (red
ginseng, white ginseng, tiny ginseng roots, and ginseng leaves) were
dissolved in 2 liters of citrate bu¡er (pH 4.0) and incubated with 10 g of
naringinase (Sigma St. Louis, MO) or 10 g of pectinase (Novozyme
Krogshoejvej, Bagsvaerd) for 48 h at 381C. When the enzymatic
hydrolysis reaction was complete, the reaction mixture was extracted with
2 liters of ethyl acetate. After evaporation in vacuo, 2.8 g of the residue was
obtained. To obtain pure ginsenoside F1, the resulting products were
separated through silica gel column chromatography and eluted with
chloroform:methanol (9:1). Further elution with chloroform:methanol
(6:1) a¡orded the pure ginsenoside F1 (0.28 g). The identi¢cation was done
by FAB-MS, 1H-NMR, and 13C-NMR spectra and the purity was
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assessed by high performance liquid chromatography and determined to be
about 96%. Ginsenoside F1was dissolved in 100% ethanol to make a stock
solution. Ethanol concentration was kept below 0.001% in all the cell cultures
and did not exert any detectable change in cell growth or apoptosis.
Cell cuture and ginsenoside F1 treatment Human HaCaT
keratinocytes were obtained from Dr Fusenig of the German Cancer
Research Center (DKFZ) and the cells (1.5^2105 cells per well) placed
in six-well plates were cultured in Dulbecco’s modi¢ed Eagle’s medium
supplemented with 10% fetal bovine serum for 24 h. After serum
starvation for 24 h, medium was replaced by serum-free medium with
various concentrations of ginsenoside F1, and cells were incubated for
24 h prior to irradiation with UVB.
UVB irradiation Ginsenoside-F1-treated or untreated HaCaT cells were
rinsed twice with PBS and exposed to various doses of UVB (0^120 mJ
per cm2), the intensity of which was monitored with an IL-1700
radiometer. A UVB radiation source was provided by a bank of Sankyo
Denki G15T8E, a £uorescent bulb emitting 270^320 nm wavelength with
a peak at 313 nm. Further, a Kodacel cellulose ¢lm (Kodacel TA401/407)
was used to completely eliminate UVC radiation. After UVB exposure,
cells were replenished with serum-free medium including ginsenoside F1
and followed up to 24 h.
Cell viability assay To determine cell viability, Trypan blue dye
exclusion and 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyltetrazolium
bromide (MTT) assays were performed at 24 h after treatment with
di¡erent doses of ginsenoside F1 (1, 5, 10, 50 mm) in HaCaT cells as
described by Fumelli et al (2000). The results of MTT assays were
expressed as optical density units (OD) using an ELISA reader (Thermo
Max, Molecular Devices, Sunnyvale, CA) at 540 nm. At 24 h after UVB
irradiation (0^120 mJ per cm2), the relative number of living cells was
detected by MTT assay. The ratio of viable cells was expressed as a
percentage of the OD value obtained without UVB treatment.
Analysis of DNA fragmentation At 24 h after UVB irradiation,
ginsenoside-F1-treated and untreated HaCaT cells were analyzed by
TUNEL staining and DNA fragmentation assay. TUNEL staining was
performed with the TUNEL Apoptosis Detection Kit (Upstate, New
York), as recommended by the manufacturer. The biotin-labeled nuclei
cells were detected by £uorescein isothiocyanate (FITC) avidin. Nuclei
were counterstained using propidium iodide and cells were analyzed
under a £uorescence microscope. For analysis of DNA fragmentation,
DNAwas isolated from the cells as described by Baba et al (1998). Twenty
microgram of DNAwas subjected to 2% agarose gel electrophoresis.
RT-PCR mRNA was extracted from cultures using Oligotex Direct
mRNA kits (Qiagen, Hilden, Germany), following the manufacturer’s
instructions. One microgram of mRNA was used as template for
quantitative RT-PCR. cDNA synthesis and PCR ampli¢cation were
performed using the Platinum Quantitative RT-PCRThermoScript One-
Step System (Invitrogen Grand Island, NY), according to the instructions
of the manufacturer.
For speci¢c human Bcl-2 or Bax ampli¢cation, the oligonucleotides 50 -
TACGATAACCGGGAGATAGTGA-30 (sense, bases 56^77 of human Bcl-2
cDNA) and 50 -CAGGTGCCGGTTCAGGTACT-30 (antisense, bases 566^
586 of human Bcl-2 cDNA) or the oligonucleotides 50 -CAAGAAGC
TGAGCGAGTGTCT-30 (sense, bases 220^240 of human Bax cDNA) and
50 -GGTTCTGATCAGTTCCGGCAC-30 (antisense, bases 437^457 of
human Bax cDNA) were used. For speci¢c human glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) cDNA ampli¢cation, the oligo-
Figure1. Structure of ginsenoside F1.
Table I. E¡ect of ginsenoside F1 on the viability and
cytotoxicity of HaCaTcellsa
Ginsenoside F1 Trypan blue, %7SDb MTT, OD7SDb
Control 92.7376.30 1.22970.03
1 mm 90.0772.89 1.20470.10
5 mm 91.1472.92 1.25270.09
10 mm 89.0873.00 1.21070.05
50 mm 56.4574.56 0.70470.10
aHaCaTcells were treated with the indicated concentration of ginsenoside F1 for
24 h.
bData are mean7SD of triplicate determinations.
Figure 2. Ginsenoside F1 prevents UVB-induced cell death. (A) Ha-
CaTcells were treated for 24 h with di¡erent doses of ginsenoside F1 (0, 1, 5,
10 mm) and were then exposed to UVB radiation with increasing intensi-
ties, as indicated. At 24 h after UVB irradiation, viability was assessed by
MTT assay. Results are expressed as the mean7SD of six di¡erent experi-
ments. Student’s t test was used for comparison of the means. (B) HaCaT
cells were incubated with (b, d) or without (a, c) ginsenoside F1 (5 mm) for
24 h and then irradiated with 60 mJ per cm2 UVB. (d) Phase-contrast mi-
croscopy 24 h after irradiation showed enhanced survival in ginsenoside-
F1-treated cells.
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nucleotides 50 -CAACTACATGGTTTACATGTTCC-30 (sense, bases 174^
194 of human GAPDH cDNA) and 50 -GGACTGTGGTCATGAGTCCT-
30 (antisense, bases 570^589 of human GAPDH cDNA) were used (Suschek
et al, 1999). For semiquantitative analysis, agarose gels were scanned by
video documentation and the images were analyzed using the
ImageMaster 2D Elite software (Amersham Biosciences Buckingham-
shire, UK). Relative Bcl-2 and Bax mRNA expression was calculated by
normalization to the expression of GAPDH.
Immunoblot analysis At 24 h after UVB irradiation (60 mJ per cm2),
ginsenoside-F1-treated or untreated cells were washed with PBS and lyzed
on ice in RIPA bu¡er pH 8.5, as described elsewhere (Rodeck et al, 1997).
Forty micrograms of total protein were analyzed under reducing
conditions on 8% sodium dodecyl sulfate/polyacrylamide gels and blotted
onto nitrocellulose membrane. The blot was incubated with an anti-Bax
(0.5 mg per ml, Santa Cruz, Santa Cruz, CA), anti-Bcl-2 (2 mg per ml,
Santa Cruz), anti-poly(ADP-ribose) polymerase (anti-PARP) (1 mg per
ml, Santa Cruz), anti-Rb (2 mg per ml, Santa Cruz), anti-c-myb (2 mg
per ml, Santa Cruz), anti-Brn-3a (2 mg per ml, Santa Cruz), and anti-Hsp
70 (0.5 mg per ml, Santa Cruz) polyclonal antibody. The reaction products
were detected by chemiluminescence with the ECL kit (Amersham
Biosciences) according to the manufacturer’s instructions. Anti-Hsp 70
antibody was used to assess equal loading of the protein.
Plasmid constructs Plasmid constructs were carried out according
to the method described by Smith et al (1998). Brie£y, full-length human
Brn-3a cDNA was ampli¢ed by PCR using primers 50 -GGATC
CATGATGTCCATGAACAGCAAGCAGCC-30 and 50 -GAATTCGTAAG
TGGCAGAGAATTTCATCCG-30 with human brain, whole Mara-
thon-Ready cDNA (Clontech Palo Alto, CA) as template, and subcloned
into the BamHI and EcoRI sites of pcDNA4/TO/myc-His A (Invitro-
gen). The human Bcl-2 P2 promoter region (spanning between ^746
and ^8 bp relative to the ATG; Smith et al, 1998) were cloned upstream
of the luciferase reporter gene in the pGL3 luciferase basic vector
(Promega, Madison, WI). Correctness of all constructs was veri¢ed by
sequencing.
Transient transfections Cells (1105 cells) were transiently transfected
with 10 mg of the promoterreporter plasmid and 10 mg of the Brn-3a
expression vector together with 2 mg of pCMV-b-galactosidase control
vector using 10 mg of lipofectamine (Invitrogen) reagent, following the
directions of the manufacturer. Transfected cells were treated with
ginsenoside F1 and irradiated by UVB as described above. The e⁄ciency
of transfection of each sample was determined with a chemiluminescence
assay for b-galactosidase activity using a commercial kit (Galactolight Plus,
Tropics), and the values were subsequently used to equalize the values
obtained from luciferase assays.
Figure 3. Ginsenoside F1 protects HaCaT cells from UVB-induced
apoptosis. (A) HaCaT cells were incubated 24 h before UVB irradiation
(60 mJ per cm2) with or without ginsenoside F1 (5 mm). At 24 h after
UVB irradiation, apoptotic nuclei or fragmented DNAwere visualized using
propidium iodide counterstaining or TUNEL staining. (B) About 200 cells
were counted and labeled nuclei were expressed as a percentage of the total
number of nuclei. Results are expressed as the mean7SD of three experi-
ments. Student’s test was used for comparison of the means. (C) DNAwas
extracted from ginsenoside-F1-treated or untreated cells with or without
UVB irradiation. DNAwas electrophoresed on 2% agarose gel.
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Luciferase assays Assays of luciferase activity were carried out using a
commercially available kit (Promega, Madison, WI) and a Turner
luminometer.
RESULTS
Ginsenoside F1 does not a¡ect the vital parameters of
HaCaT cells up to a concentration of 10 lm In order to
understand the e¡ects of ginsenoside F1 on HaCaT cells, we
evaluated a possible alteration of vital parameters. Increasing
doses of ginsenoside F1 (1^10 mm) did not cause HaCaT cell
cytotoxicity as shown by Trypan blue dye exclusion and MTT
(Table I). A concentration of 50 mm of ginsenoside F1 displayed
a little cytotoxic e¡ect in HaCaT keratinocytes.
Ginsenoside F1 protects HaCat cells from UVB-induced
apoptosis In order to study the e¡ects of ginsenoside F1 in
UVB-induced HaCaT cell apoptosis, we used di¡erent doses of
ginsenoside F1 in HaCaT cell cultures before the irradiation with
di¡erent doses of UVB. As expected, UVB radiation drastically
reduced viability of HaCaT cells in a dose-dependent manner.
On the other hand, we observed a signi¢cant increase of viable
cells in ginsenoside-F1-treated cells compared with untreated
cells (Fig 2A). Indeed, the treatment with 5 mM ginsenoside F1
led to maximal protective e¡ects against UVB-induced cell
death. At a UVB dose of 120 mJ per cm2, however, ginsenoside-
F1-treated cells showed a higher susceptibility to apoptosis
than did untreated cells. UVB irradiation induced distinct
morphologic alterations in HaCaT cells, which became round
and detached from the plate (Fig 2B, c), whereas the treatment
with ginsenoside F1 prevented this alteration, as shown by the
morphology of the cells (Fig 2B, d).
To further investigate the protective e¡ect of ginsenoside F1
against UVB-induced apoptotic cell death,TUNEL staining and
DNA fragmentation assay were performed at 24 h after UVB
irradiation using the ginsenoside-F1-treated or untreated cells.
As shown in Fig 3, apoptotic nuclei and DNA strand breakages
were clearly observed in untreated HaCaT cells at 24 h following
60 mJ per cm2 UVB irradiation. The DNA cleavage, however,
was reduced in ginsenoside-F1-treated cells.
During the UVB-induced apoptosis, caspase-3 is activated and
cleaves several other apoptotic proteins such as PARP. We also
examined apoptotic cleavage of the caspase-3 substrate PARP to
its 85 kDa form by immunoblot analysis following 60 mJ
per cm2 UVB irradiation of HaCaT cells. Cleavage of PARP,
as shown by the 85 kDa band, was observed at 24 h post-
irradiation in untreated cells (Fig 4). In contrast, ginsenoside F1
markedly diminished the generation of the 85 kDa PARP
fragment in HaCaT cells.
Figure 4. Ginsenoside F1 reduces UVB-induced PARP cleavage.
HaCaT cells were incubated 24 h before UVB irradiation (60 mJ per cm2)
with or without ginsenoside F1 (5 mm). PARP cleavage was determined by
immunoblot analysis 24 h after radiation. Equal loading of protein lysates
was con¢rmed by anti-Hsp 70 antibody.
Figure 5. E¡ects of ginsenoside F1 and UVB on Bcl-2 and Bax mRNA expression. Cells were treated with (B, D) or without (A, C) ginsenoside F1
(5 mm) and harvested at di¡erent time-points prior to UVB radiation or post-UVB radiation (60 mJ per cm2). Using quantitative RT-PCR, we examined
the e¡ects of ginsenoside F1 and UVB on the Bcl-2 and Bax mRNA expression of HaCaT cells, as described in Materials and Methods.
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Taken together, these results demonstrate that ginsenoside F1
exerts an e¡ective protection from UVB-induced apoptosis in
HaCaT cells.
Ginsenoside F1 prevents UVB-induced downregulation
of Bcl-2 in HaCaT cells In search of the molecular
mechanism(s) responsible for the protective e¡ects, we examined
the mRNA expression and the relative amounts of the two
proteins Bax and Bcl-2 in UVB-irradiated HaCaT cells with or
without treatment with ginsenoside F1.
Fig. 5 shows the e¡ects of ginsenoside F1 or UVB irradiation
on Bcl-2 and Bax mRNA expression. GAPDH is used as a
housekeeper gene to normalize the Bcl-2 and Bax genes. No
di¡erence in Bcl-2 mRNA expression was detected between
ginsenoside-F1-treated and untreated cells in the absence of
UVB irradiation. At 12 h after UVB irradiation, Bcl-2 mRNA
expression levels were almost abolished in untreated HaCaT cells
(Fig 5A). On the other hand, Bcl-2 levels in ginsenoside-F1-
treated cells were not downregulated by UVB irradiation (Fig
5B), compared with those in unirradiated cells. The expression
of Bax mRNA was not signi¢cantly changed after UVB
irradiation with or without treatment with ginsenoside F1
(Fig 5C, D).
The pattern of protein expression of Bcl-2 and Bax was similar
to that of their mRNA expression (Fig 6).
Ginsenoside F1 counteracts the UVB-induced down-
regulated Brn-3a expression in HaCaT cells Although it is
widely accepted that UVB irradiation decreases the level of Bcl-2
expression, the exact mechanism by which UVB downregulates
the expression of Bcl-2 remains unclear. To understand the
molecular mechanism for the inhibitory e¡ect of ginsenoside F1
on UVB-induced downregulation of Bcl-2, we examined the
expression patterns of various transcription factors that had been
shown to regulate transcription of Bcl-2. c-myb has been shown
to induce Bcl-2 promoter activity in murine T cells (Taylor et al,
1996) and Rb has been reported to activate transcription of Bcl-2
in epithelial cells by interacting with the activator protein 2
transcription factor (Decary et al, 2002). Brn-3a interacts with
the P2 promoter of Bcl-2 gene and activates endogenous Bcl-2
expression in neuronal cells (Smith et al, 1998).
At 24 h after UVB radiation, protein extracts from the
ginsenoside-F1-treated or untreated HaCaT cells were subjected
to immunoblot with antibodies raised to c-myb, Rb, and
Brn-3a. No di¡erence in c-myb or Rb protein expression
was detected between ginsenoside-F1-treated and untreated cells
following UVB irradiation (Fig 7).
The level of Brn-3a protein expression was reduced by UVB
irradiation in HaCaT cells. Interestingly, the UVB-induced
reduction of Brn-3a expression was dramatically restored upon
treatment with ginsenoside F1 (Fig 7), suggesting that Brn-3a
transcription factor may be involved in the antiapoptotic e¡ect
of ginsenoside F1 through the induction of Bcl-2.
Overexpression of Brn-3a overcomes the repression of Bcl-2
promoter activity caused by UVB irradiation To establish a
correlation between Brn-3a and Bcl-2 expression in UVB-
irradiated HaCaT cells, we performed transient transfection
assays. Bcl-2 P2 luciferase reporter construct contains the 738 bp
of regulatory sequence immediately upstream of the Bcl-2 P2
promoter region (spanning ^746 to ^8 bp), which has been
shown to be responsive to Brn-3a transcription factor (Smith et
al, 1998). HaCaT cells were transfected with the Bcl-2 P2
luciferase reporter constructs following the treatment with
ginsenoside F1 and UVB irradiation. Whereas UVB irradiation
resulted in a 4-fold decrease in luciferase activity in untreated
HaCaT cells, no change was observed in luciferase activity in
ginsenoside-F1-treated cells, compared with unirradiated cells
(Fig 8). To determine if the overexpression of Brn-3a overcomes
the repression of luciferase activity under Bcl-2 promoter control
caused by UVB irradiation, HaCaT cells were cotransfected with
the Bcl-2 P2 luciferase reporter construct and the pBrn-3a
expression vector or empty expression vector followed by
exposure to UVB. Cotransfection of HaCaT cells with the Brn-
3a expression vector restored the decrease of luciferase activity
caused by UVB irradiation (Fig 8). These data suggest that
UVB irradiation may downregulate Bcl-2 expression via a
downregulation of Brn-3a transcription factor in HaCaT cells,
and ginsenoside F1 may overcome the repression of Bcl-2
promoter activity via upregulation of Brn-3a expression in
UVB-irradiated cells.
DISCUSSION
Ginseng is a highly valued herb in the Far East and has gained
popularity in the West during the last decade. The major active
components of ginseng are ginsenosides, a diverse group of ster-
oidal saponins, which demonstrate the ability to target a myriad
of tissues, producing an array of pharmacologic responses (Gillis,
1997). Many mechanisms of ginsenoside activities still remain un-
known, however.
In this study we ¢rst demonstrate that ginsenoside F1 protects
human HaCaTcells from UVB-induced damage in vitro. In parti-
cular, ginsenoside F1 e¡ectively reduced cell death and apoptotic
Figure 6. E¡ects of ginsenoside F1 and UVB on Bcl-2 and Bax pro-
tein expression. Cells were treated with (B) or without (A) ginsenoside
F1 (5 mm) and harvested at di¡erent time-points prior to UVB radiation or
post-UVB radiation (60 mJ per cm2).The expression of Bcl-2 and Bax pro-
tein was examined by immunoblots as described in Materials and Methods.
Equal loading of protein lysates was con¢rmed by anti-Hsp 70 antibody.
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DNA cleavage after UVB radiation. In addition, we show that
Bcl-2 mRNA expression was not a¡ected by UVB in ginseno-
side-F1-treated HaCaT cells, whereas it was markedly downregu-
lated in untreated cells. Thus, it is conceivable that ginsenoside F1
protects human HaCaT cells from UVB-induced apoptosis by
maintaining constant levels of Bcl-2. Furthermore, this positive
regulation of Bcl-2 might be mediated by Brn-3a transcription
factors (Pit-1, Oct-1 and Oct-2, unc-86) binding domain (POU)
domain transcription factor in ginsenoside-F1-treated HaCaT cells.
Brn-3a, a member of the Brn-3 family of type IV POU do-
main transcription factors, protects sensory neurons from apopto-
tic programmed cell death (Smith et al, 1997). The antiapoptotic
e¡ect of Brn-3a is mediated via the upregulation of Bcl-2 expres-
sion. Brn-3a interacts with the P2 promoter of Bcl-2 gene and
activates endogenous Bcl-2 expression in neuronal cells (Smith
et al, 1998). Our experiments showed that UVB irradiation caused
a decrease in Bcl-2 and Brn-3a expression in HaCaTcells, but not
in ginsenoside-F1-treated cells (Figs 6, 7). Furthermore, overex-
pression of Brn-3a overcame the repression of Bcl-2 promoter
activity caused by UVB irradiation (Fig 8). These data suggest
that the positive regulation of Bcl-2 gene by Brn-3a provides
a possible pathway by which ginsenoside F1 is able to confer
HaCaT cells with resistance to UVB-induced apoptosis. Further
experiments are needed to precisely de¢ne the molecular mecha-
nism by which ginsenoside F1 a¡ects the expression of Bcl-2.We
also have to test whether HaCaT cells are resistant to UVB-in-
duced apoptosis when the cells are stably transfected with Brn-3a.
UVB radiation activates caspase-3, which cleaves several other
apoptotic proteins such as PARP (Mellroy et al, 1999). During the
apoptosis, PARP is cleaved from the 116 kDa intact form into the
85 kDa form. Recently, it has been reported that Bcl-2 can pro-
tect cells from apoptosis by acting at a point downstream from
release of mitochondrial cytochrome c, thereby preventing a cas-
pase-3-dependent proteolytic cascade (Swanton et al, 1999). In our
study, treatment of ginsenoside F1 inhibited UV-induced PARP
cleavage in HaCaT cells, suggesting that this molecule may pre-
vent caspase activation through a Bcl-2-mediated antiapoptotic
pathway.
The death-suppressing activity of Bcl-2 is regulated by Bax,
which promotes cell death.The ratio of these two proteins is con-
sidered to be important when determining whether the cell un-
dergoes apoptosis after an appropriate stimulus (Yang and
Korsmeyer, 1996). Previously, it has been shown that Bcl-2 ex-
pression is reduced after UVB irradiation in rat and mouse skin
(Gillardon et al, 1994; Li et al, 1996), but, in contrast, the expression
of Bax is not changed (Gillardon et al, 1994). Our experiments
also showed that neither UVB nor ginsenoside F1 had any in£u-
ence on Bax mRNA expression.
In conclusion, these data demonstrate that ginsenoside F1 pro-
tects HaCaT keratinocytes from UVB-induced apoptosis, at least
in part through the Brn-3a-mediated transcriptional regulation of
Bcl-2.Thus, these results suggest a new rationale for use of ginse-
noside F1 to prevent UVB-induced skin damage.
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